Pfizer Group B strep vaccine for infants returns encouraging mid-stage trial results - Stock Check Updates

Breaking

Wednesday, July 19, 2023

Pfizer Group B strep vaccine for infants returns encouraging mid-stage trial results

Pfizer is among several drugmakers racing to develop the world's first shot targeting Group B strep disease, which kills thousands of infants each year.

from International: Top News And Analysis https://ift.tt/0iR5clH
via IFTTT

No comments:

Post a Comment